Published in Ann N Y Acad Sci on January 01, 1986
Immune aspects of sarcoidosis. Postgrad Med J (1988) 1.04
Genome organization and transactivation of the human immunodeficiency virus type 2. Nature (1987) 11.79
Isolation of a new human retrovirus from West African patients with AIDS. Science (1986) 7.97
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. J Mol Biol (1990) 4.38
HIV-1 reverse transcription. A termination step at the center of the genome. J Mol Biol (1994) 4.15
Transmission of antiretroviral-drug-resistant HIV-1 variants. Lancet (1999) 3.43
A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J Virol (1992) 3.39
Resistance of human immunodeficiency virus type 1 to protease inhibitors: selection of resistance mutations in the presence and absence of the drug. J Gen Virol (1996) 2.95
Resistance-associated loss of viral fitness in human immunodeficiency virus type 1: phenotypic analysis of protease and gag coevolution in protease inhibitor-treated patients. J Virol (1998) 2.92
Molecular cloning and polymorphism of the human immune deficiency virus type 2. Nature (1987) 2.86
Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1. J Virol (1998) 2.82
Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity. J Virol (1995) 2.45
Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. N Engl J Med (1987) 2.32
Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: virus fitness in the absence and in the presence of drug. J Virol (2000) 2.27
Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus. Virology (1985) 2.23
Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci U S A (1994) 2.21
Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons. J Virol (1992) 2.15
Impaired replication of protease inhibitor-resistant HIV-1 in human thymus. Nat Med (2001) 2.13
Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy. J Virol (2001) 2.08
Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection. J Clin Invest (1999) 2.00
A single-stranded gap in human immunodeficiency virus unintegrated linear DNA defined by a central copy of the polypurine tract. J Virol (1991) 1.90
Pleural effusion: laboratory tests in 300 cases. Thorax (1979) 1.85
Determination of coreceptor usage of human immunodeficiency virus type 1 from patient plasma samples by using a recombinant phenotypic assay. J Virol (2001) 1.79
Discordant increases in CD4+ T cells in human immunodeficiency virus-infected patients experiencing virologic treatment failure: role of changes in thymic output and T cell death. J Infect Dis (2001) 1.62
Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis. J Clin Invest (1985) 1.54
Relative validity and reproducibility of a French dietary history questionnaire. Int J Epidemiol (1997) 1.54
Analysis of HIV cross-resistance to protease inhibitors using a rapid single-cycle recombinant virus assay for patients failing on combination therapies. AIDS (1999) 1.52
Lymphadenopathy-associated virus type 2 in AIDS and AIDS-related complex. Clinical and virological features in four patients. Lancet (1987) 1.49
Deficient LAV1 neutralising capacity of sera from patients with AIDS or related syndromes. Lancet (1985) 1.48
Selection of virus variants and emergence of virus escape mutants after immunization with an epitope vaccine. J Virol (1998) 1.47
Kinetic analysis of HIV-1 early replicative steps in a coculture system. AIDS Res Hum Retroviruses (1994) 1.46
Isolation and envelope sequence of a highly divergent HIV-1 isolate: definition of a new HIV-1 group. Virology (1994) 1.46
Coupling of Organic Halides with Carbonyl Compounds Promoted by SmI(2), the Kagan Reagent. Chem Rev (1999) 1.42
Evolution of cytotoxic T lymphocyte responses to human immunodeficiency virus type 1 in patients with symptomatic primary infection receiving antiretroviral triple therapy. J Infect Dis (1998) 1.39
Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral products. J Clin Invest (1997) 1.39
A highly defective HIV-1 group O provirus: evidence for the role of local sequence determinants in G-->A hypermutation during negative-strand viral DNA synthesis. Virology (1995) 1.38
Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells. J Virol (1997) 1.38
Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector. Eur J Immunol (1995) 1.36
Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix. A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract. J Clin Invest (1984) 1.29
Pulmonary histiocytosis X. Am Rev Respir Dis (1978) 1.28
Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis. Ann N Y Acad Sci (1986) 1.27
Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation. Virology (1996) 1.26
A monoclonal antibody against LAV gag precursor: use for viral protein analysis and antigenic expression in infected cells. J Immunol (1986) 1.25
Lymphadenopathy-associated virus isolated from bronchoalveolar lavage fluid in AIDS-related complex with lymphoid interstitial pneumonitis. N Engl J Med (1985) 1.21
Effects of human immunodeficiency virus type 1 resistance to protease inhibitors on reverse transcriptase processing, activity, and drug sensitivity. J Virol (1999) 1.13
Central nervous system as a sanctuary for HIV-1 infection despite treatment with zidovudine, lamivudine and indinavir. AIDS (1997) 1.10
AIDS and related syndromes as a viral-induced autoimmune disease of the immune system: an anti-MHC II disorder. Therapeutic implications. AIDS Res (1986) 1.08
Helping people to stop smoking: randomised comparison of groups being treated with acupuncture and nicotine gum with control group. Br Med J (Clin Res Ed) (1985) 1.07
Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assay. Clin Vaccine Immunol (2006) 1.05
Processing of lung lavage fluid causes variability in bronchoalveolar cell count. Am Rev Respir Dis (1984) 1.04
Comparison of genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 isolates from patients treated with stavudine and didanosine or zidovudine and lamivudine. J Infect Dis (2001) 1.03
The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis. J Gen Virol (1998) 1.02
Kinetics of antiviral activity and intracellular pharmacokinetics of human immunodeficiency virus type 1 protease inhibitors in tissue culture. Antimicrob Agents Chemother (1999) 1.02
Type 1 CD4(+) T-cell help is required for induction of antipeptide multispecific cytotoxic T lymphocytes by a lipopeptidic vaccine in rhesus macaques. J Virol (1999) 1.02
Effect of oestradiol on cell proliferation and histological changes in the uterus and vagina of mice. J Endocrinol (1971) 1.02
Effects of cyclosporin on T-cell subsets in human immunodeficiency virus disease. Clin Immunol Immunopathol (1988) 1.00
Simian immunodeficiency virus as a model for vaccination against HIV. Induction in rhesus macaques of GAG- or NEF-specific cytotoxic T lymphocytes by lipopeptides. J Immunol (1994) 1.00
Bronchoalveolar lymphocytosis in patients with tropical spastic paraparesis associated with human T-cell lymphotropic virus type 1 (HTLV-1). Clinical, immunologic, and cytologic studies. Ann Intern Med (1988) 0.99
Bronchoalveolar lavage in acquired immunodeficiency syndrome. Lancet (1983) 0.98
Highly active antiretroviral treatment initiated early in the course of symptomatic primary HIV-1 infection: results of the ANRS 053 trial. J Infect Dis (1999) 0.97
Pulmonary complications of intravesical Bacille Calmette-Guérin immunotherapy. Am Rev Respir Dis (1987) 0.97
Reversion of a polymerase-defective integrated HIV-1 genome. AIDS Res Hum Retroviruses (1993) 0.96
Constrained evolution of human immunodeficiency virus type 1 protease during sequential therapy with two distinct protease inhibitors. J Virol (1999) 0.95
Unusual pulmonary infection in a puzzling presentation of AIDS. Lancet (1985) 0.95
[Autonomous intrathoracic goiter. Apropos of 2 new cases]. Rev Pneumol Clin (1986) 0.95
Serum HIV antigen and anti-P24-antibodies in 200 HIV seropositive patients: correlation with CD4 and CD8 lymphocyte subsets. Clin Exp Immunol (1988) 0.94
Variations in the risk of breast cancer associated with a family history of breast cancer according to age at onset and reproductive factors. J Clin Epidemiol (1993) 0.92
Dissemination of SIV after rectal infection preferentially involves paracolic germinal centers. Virology (1999) 0.90
Altered ex vivo balance between CD28+ and CD28- cells within HIV-specific CD8+ T cells of HIV-seropositive patients. Eur J Immunol (1999) 0.90
Respiratory clearance of 99mTc-DTPA and pulmonary involvement in sarcoidosis. Am Rev Respir Dis (1986) 0.89
Effects of inflammation and fibrosis on pulmonary function in diffuse lung fibrosis. Thorax (1990) 0.89
Exposure to vinyl chloride monomer: report on a cohort study. Br J Ind Med (1987) 0.89
Elevation of the bronchoalveolar concentration of angiotensin I converting enzyme in sarcoidosis. Am Rev Respir Dis (1982) 0.88
Respiratory tract fluids: analysis of content and contemporary use in understanding lung diseases. Dis Mon (1984) 0.88
Primary and recombinant HIV type 1 strains resistant to protease inhibitors are pathogenic in mature human lymphoid tissues. AIDS Res Hum Retroviruses (2001) 0.88
Breast cancer and oral contraceptives: a review. Contraception (1985) 0.87
HIV isolation from pulmonary cells derived from bronchoalveolar lavage. Clin Exp Immunol (1991) 0.87
Occupational exposure and cancer of the pancreas: a review. Br J Ind Med (1991) 0.87
Cholangitis in the acquired immunodeficiency syndrome: report of two cases and review of the literature. Gut (1987) 0.87
Five cases of immune-mediated amiodarone pneumonitis. Lancet (1984) 0.86
Human alveolar macrophage subpopulations isolated on discontinuous albumin gradients: functional data in normals and sarcoid patients. Eur J Respir Dis (1986) 0.86
[Epithelioid cell. Ultrastructural data during various pathological conditions]. Pathol Biol (Paris) (1975) 0.85
Persistent high alveolar lymphocytosis as a predictive criterion of chronic pulmonary sarcoidosis. Ann N Y Acad Sci (1986) 0.84
Impairment of beta chemokine and cytokine production in patients with HIV related Pneumocystis jerovici pneumonia. Thorax (2004) 0.84
A study of pulmonary dust deposits using the electron microscope in conjunction with the electron sound analyser. Thorax (1972) 0.84
Familial risk of breast cancer and abortion. Cancer Detect Prev (1994) 0.84
Three epitopic peptides of the simian immunodeficiency virus Nef protein recognized by macaque cytolytic T lymphocytes. J Virol (1992) 0.84
Occupational risk factors for cancer of the pancreas: a case-control study. Br J Ind Med (1990) 0.84
Longitudinal analysis of CD8(+) T-cell phenotype and IL-7, IL-15 and IL-16 mRNA expression in different tissues during primary simian immunodeficiency virus infection. Microbes Infect (2001) 0.83
Serum suppressive activity of HIV seropositive patients. Clin Exp Immunol (1988) 0.83
The mitogenic action of ovarian hormones on the uterine and the vaginal epithelium during the oestrous cycle in the rat: a radioautographic study. J Endocrinol (1969) 0.83
[Study of pulmonary dust particles under the electron microscope and with electronic probe micro analyzer]. Presse Med (1970) 0.83